Patents Assigned to Solace Therapeutics, Inc.
-
Patent number: 11197981Abstract: An pressure attenuation device for use in a body can include a balloon comprising an outer wall and defining an interior chamber therein. The balloon can be configured to elastically deform up to at least to an internal pressure of 90 cm H2O. A high vapor pressure media having a vapor pressure of between 155 cm-185 cm H2O at 37 degrees Celsius can be positioned within the interior chamber. The balloon can have a minimum wall thickness of between 0.001 inches-0.00175 inches.Type: GrantFiled: April 23, 2020Date of Patent: December 14, 2021Assignee: Solace Therapeutics, Inc.Inventors: Kevin G. Connors, Albert Chun-Chi Chin, Roy H. Sullivan, III, Matthew J. Whitney, William H. Gruber
-
Patent number: 10799268Abstract: Method and system for treating a patient using a compressible, pressure-attenuating device. According to one embodiment, the system is used to treat urinary tract disorders and comprises an access device, a delivery device, a pressure-attenuating device, and a removal device. The access device may be used to create a passageway to an anatomical structure, such as the patient's bladder. The delivery device may be inserted through the passageway created by the access device and may be used to deliver the pressure-attenuating device to the anatomical structure. The removal device may be inserted through the passageway created by the access device and may be used to view the bladder and/or to capture, to deflate and to remove the pressure-attenuating device.Type: GrantFiled: April 10, 2018Date of Patent: October 13, 2020Assignee: SOLACE THERAPEUTICS, INC.Inventors: Kevin G. Connors, Ryan J. Cahill, Peter Dayton, John Gillespie, Jr.
-
Patent number: 10543071Abstract: Method and system for treating a patient using a compressible, pressure-attenuating device. According to one embodiment, the system is used to treat urinary tract disorders and can include one or more of an access device, a delivery device, a pressure-attenuating device, and a removal device. The access device may be used to create a passageway to an anatomical structure, such as the patient's bladder. The delivery device may be inserted through the passageway created by the access device and may be used to deliver the pressure-attenuating device to the anatomical structure. The removal device may be inserted through the passageway created by the access device and may be used to view the bladder and/or to capture, to deflate and to remove the pressure-attenuating device.Type: GrantFiled: August 8, 2013Date of Patent: January 28, 2020Assignee: SOLACE THERAPEUTICS, INC.Inventors: Ryan J. Cahill, Scott Duncan, Kevin G. Connors, William Gruber, John Gillespie, Jr., Sheila Caira
-
Patent number: 10531894Abstract: Method and system for treating a patient using a compressible, pressure-attenuating device. According to one embodiment, the system is used to treat urinary tract disorders and comprises an access device, a delivery device, a pressure-attenuating device, and a removal device. The access device may be used to create a passageway to an anatomical structure, such as the patient's bladder. The delivery device may be inserted through the passageway created by the access device and may be used to deliver the pressure-attenuating device to the anatomical structure. The removal device may be inserted through the passageway created by the access device and may be used to view the bladder and/or to capture, to deflate and to remove the pressure-attenuating device.Type: GrantFiled: September 20, 2017Date of Patent: January 14, 2020Assignee: Solace Therapeutics, Inc.Inventors: Kevin G. Connors, Ryan J. Cahill, Peter Dayton, John Gillespie, Jr.
-
Patent number: 10383510Abstract: An implant delivery system can be configured to deliver an inflatable implant into a bladder via a urethra. The delivery system can comprise an elongate tubular body, an inflation tube and an implant decoupler. The tubular body can comprise a central lumen configured to hold an inflatable implant in an initial un-inflated state for delivery of the implant into the bladder. A method of use can include passing a distal tip of the elongate tubular body into the bladder. The implant can be inflated and released into the bladder.Type: GrantFiled: October 14, 2016Date of Patent: August 20, 2019Assignee: SOLACE THERAPEUTICS, INC.Inventors: Ernest G. Schutt, Kevin G. Connors, John Gillespie, Jr., Peter Dayton
-
Patent number: 7074178Abstract: Disclosed herein are methods of treating a patient, comprising providing a compressible attenuation device that is moveable from a first, introduction configuration to a second, implanted configuration. The attenuation device is introduced into a treatment site. In one embodiment, the treatment site is the bladder. In another embodiment, the treatment site is the abdominal cavity. The volume of the attenuation devices changes in response to pressure changes in the treatment site and attenuates pressure changes in the bladder.Type: GrantFiled: March 17, 2003Date of Patent: July 11, 2006Assignee: Solace Therapeutics, Inc.Inventors: Kevin G. Connors, William L. Pintauro, Sheila K. Wallin, John T. Kilcoyne, Hung H. Cao, Khoi M. Nguyen, Matthew T. Yurek
-
Patent number: 6988983Abstract: Disclosed herein is an attenuation device comprising a flexible housing and a medium capable of transformation to inflate the housing from the first configuration to the second configuration. Also disclose herein are methods of treating a patient, comprising: providing a self-inflating expandable attenuation device, containing a medium which is transformable from a first, reduced volume to a second, expanded volume; positioning the attenuation device within the patient at a treatment site; and transforming the medium from the first volume to the second volume. In one embodiment, a self-inflating expandable attenuation device is used to treat urinary tract dysfunction. In another embodiment, a self-inflating expandable attenuation device is used to treat benign hypertrophy of the prostate.Type: GrantFiled: March 17, 2003Date of Patent: January 24, 2006Assignee: Solace Therapeutics, Inc.Inventors: Kevin G. Connors, William L. Pintauro, Sheila K. Wallin, John T. Kilcoyne, Hung H. Cao, Khoi M. Nguyen, Matthew T. Yurek
-
Patent number: 6976951Abstract: Disclosed herein is an attenuation device, comprising a flexible housing and a high vapor pressure media having a vapor pressure approximately equal to the intravesical pressure of the bladder and a permeability of less than 1 ml/day at body temperature through the outer wall of the flexible housing. In one embodiment, the high vapor pressure media comprises perfluorooctylbromide. In another embodiment, the high vapor pressure media comprises perfluorohexane. In yet another embodiment, the high vapor pressure media comprises perfluorodecalin. Also disclosed herein is a method of treating a patient, comprising providing a compressible attenuation device and introducing within the attenuation device at least one high vapor pressure media.Type: GrantFiled: July 11, 2003Date of Patent: December 20, 2005Assignee: Solace Therapeutics, Inc.Inventors: Kevin G. Connors, William L. Pintauro, Sheila K. Wallin, John T. Kilcoyne, Hung H. Cao, Khoi M. Nguyen, Matthew T. Yurek
-
Patent number: 6976950Abstract: Disclosed herein are devices for treating symptoms of a urinary tract dysfunction having an expanded volume within the range of from about 1 cc to about 400 cc. In one embodiment, the device comprises a valve having a first membrane and a second membrane with a flow passage therebetween for filling the attenuation device. In another embodiment, the device comprises a valve for permitting the filling of the attenuation device through a filling device.Type: GrantFiled: March 17, 2003Date of Patent: December 20, 2005Assignee: Solace Therapeutics, Inc.Inventors: Kevin G. Connors, William L. Pintauro, Sheila K. Wallin, John T. Kilcoyne, Hung H. Cao, Khoi M. Nguyen, Matthew T. Yurek
-
Patent number: 6682473Abstract: Disclosed are pressure attenuators, for attenuating pressure changes in an anatomical structure. The attenuators are movable from a first, introduction configuration to a second, implanted configuration. When in the second, implanted configuration, the attenuator attenuates pressure spikes within the body by reversibly reducing in volume in response to the pressure spike. In one application, the attenuator is utilized to treat urinary tract dysfunctions. Deployment devices, retrieval devices, and methods are also disclosed.Type: GrantFiled: November 27, 2000Date of Patent: January 27, 2004Assignee: Solace Therapeutics, Inc.Inventors: David G. Matsuura, Walter D. Gillespie, Sheila K. Wallin, Kevin G. Connors, Edward Bullister